Ana Lledo Delgado

Ana Lledo Delgado is an Associate Researcher in the Immunobiology Department at Yale School of Medicine. She holds a medical degree from Universidad Autónoma de Madrid and advanced training in clinical medicine, research methodology, and bioinformatics. Her work focuses on autoimmune disorders, particularly Type 1 diabetes and rheumatology, combining computational methods with clinical research.

• Education: MD (2017), MSc Clinical Medicine (2018), MSc Research Methodology (2019), MSc Bioinformatics (2025)
• Residency: Rheumatology at Hospital 12 de Octubre (2018–2022)
• Lab Affiliation: Dr. Kevan Herold's lab since 2022

Research interests include EBV's role in autoimmune diseases, immunotherapies like teplizumab, and T-cell responses in viral infections. Notable achievements include awards from FOCIS and SORCOM, and contributions to understanding SARS-CoV-2 impacts on immunosuppressed patients.

Collaborations span bioinformatics projects with Yale's medical library and international studies on rheumatic diseases. Her work bridges clinical practice and computational analysis in immunology and autoimmunity.